基于网络药理学探究黄芪赤风汤治疗糖尿病周围神经病变作用机制
To Explore the Mechanism of Huangqi Chifeng Decoction in the Treatment of Diabetic Peripheral Neuropathy Based on Network Pharmacology
DOI: 10.12677/TCM.2023.128365, PDF,   
作者: 方廷丽, 刘 裔:贵州中医药大学第一临床医学院,贵州 贵阳;夏佳毅:贵州中医药大学第一附属医院,贵州 贵阳
关键词: 网络药理学黄芪赤风汤糖尿病周围神经病变Network Pharmacology Huangqi Chifeng Decoction Diabetic Peripheral Neuropathy
摘要: 目的:通过网络药理学探究黄芪赤风汤有效成分、糖尿病周围神经病变之间的网络关系,探究黄芪赤风汤作用机制。方法:通过中药系统药理学数据库分析平台(TCMSP)筛选复方黄芪赤风汤有效成分及相应的靶点;从Gene Cards数据库中获取糖尿病周围神经病变疾病相关靶点;使用在线软件平台Venny 2.1绘制药物、疾病的交集靶点维恩图;通过Metoscape数据库对交集靶点进行基因本体功能(GO)和京都基因与基因组百科全书(KEGG)通路富集分析;通过STRING在线数据库构建PPI网络,同时导入Cytoscape 3.9.1获取核心靶点;通过Cytoscape 3.9.1绘制活性成分–靶点网络。结果:黄芪赤风汤29种活性成分,共作用于232个靶点;疾病靶点1286个,疾病和药物交集靶点94个;核心靶点包括肿瘤坏死因子(TNF)、血管内皮生长因子A (VEGFA)、白细胞介素6 (IL6)、TP53、雌激素受体1 (ESR1)、蛋白激酶Bα (AKT1)、过氧化物酶(CAT)、胱天蛋白酶3 (CASP3)、过氧化物酶体增殖物激活受体γ (PPARG)、低聚果糖(FOS)等;GO富集分析在BP上主要为细胞对氧化应激、活性氧、脂质等的生物学过程,在CC上表现为细胞膜、膜微区、膜筏等结构的细胞定位,在MF上表现为肾上腺素能受体、细胞因子、配体激活转录因子等分子功能;KEGG富集分析主要包括糖尿病并发症的AGE-RAGE信号通路、流体剪切应力与动脉粥样硬化、脂质和动脉粥样硬化、癌症中的蛋白聚糖、磷脂酰肌醇3-激酶(PI3K)/蛋白激酶(Akt)信号通路、IL-17信号通路、TNF信号通路、MAPK信号通路、活性氧、HIF-1信号通路等通路。结论:黄芪赤风汤有效成分可能通过各类氧化应激、炎症相关通路作用于糖尿病周围神经病变。
Abstract: Objective: To explore the network relationship between the active components of Huangqi Chifeng Decoction and diabetic peripheral neuropathy through network pharmacology, and explore the action mechanism of Huangqi Chifeng Decoction. Methods: The effective components and corresponding targets of compound Huangqi Chifeng Decoction were screened by TCMSP. Targets related to diabetic peripheral neuropathy were obtained from GeneCards database. Venny2.1, an online software platform, was used to draw the Venn diagram of intersecting targets of drugs and diseases. Metoscape database was used to enrich gene ontology function (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways for intersection targets. PPI network was constructed using STRING online database, and Cytoscape3.9.1 was imported to obtain core targets. Map the Active Ingredient-Target network via Cytoscape3.9.1. Results: There were 29 active ingredients of Huangqi Chifeng decoction, which acted on 232 targets. There were 1286 disease targets and 94 disease and drug intersection targets. Core targets include tumor necrosis factor (TNF), vascular endothelial growth factor A (VEGFA), interleukin 6 (IL6), TP53, estrogen receptor 1 (ESR1), protein kinase Bα (AKT1), peroxidase (CAT), caspase 3 (CASP3), and peroxisome proliferator-activated receptor γ (PP) ARG), oligosaccharides (FOS), etc. In BP, GO enrichment analysis is mainly the biological process of cells to oxidative stress, reactive oxygen species, lipids, etc. In CC, it is the cell localization of cell membrane, membrane microregion, membrane raft, etc. In MF, it is the molecular function of adrenergic receptors, cytokines, ligand-activated transcription factors, etc. KEGG enrichment analysis mainly included AGE-RAGE signaling pathway in diabetes complications, fluid shear stress and atherosclerosis, lipid and atherosclerosis, proteoglycan in cancer, phosphatidylinositol 3-kinase (PI3K)/protein kinase (Akt) signaling pathway, IL-17 signaling pathway, TNF signaling pathway, and MAPK signaling pathway Pathway, reactive oxygen species, HIF-1 signaling pathway, etc. Conclusion: The active components of Huangqi Chifeng decoction may act on diabetic peripheral neuropathy through various pathways related to oxidative stress and inflammation.
文章引用:方廷丽, 刘裔, 夏佳毅. 基于网络药理学探究黄芪赤风汤治疗糖尿病周围神经病变作用机制[J]. 中医学, 2023, 12(8): 2436-2443. https://doi.org/10.12677/TCM.2023.128365

参考文献

[1] 中华医学会糖尿病学分会神经并发症学组. 糖尿病神经病变诊治专家共识(2021年版) [J]. 国际内分泌代谢杂志, 2021, 41(3): 256-272.
[2] 任建功, 陈爱荣, 刘静, 等. 2型糖尿病住院患者慢性并发症的流行病学调查及其相关因素分析[J]. 兰州大学学报(医学版), 2006, 32(1): 48-51.
[3] 陆游, 陆颖理. 糖尿病性周围神经病变发生机制的研究进展[J]. 上海交通大学学报(医学版), 2017, 37(10): 1441-1445.
[4] 纪晓佳. “消渴病痹症”的中医病因病机及辩治方法探讨[D]: [硕士学位论文]. 广州: 广州中医药大学, 2015.
[5] 祁悦, 张杰. 中医药治疗糖尿病周围神经病变的临床研究进展[J]. 时珍国医国药, 2021, 32(2): 428-432.
[6] 马艳春, 胡建辉, 吴文轩, 等. 黄芪化学成分及药理作用研究进展[J]. 中医药学报, 2022, 50(4): 92-95.
[7] 吴玲芳, 王子墨, 赫柯芊, 等. 赤芍的化学成分和药理作用研究概况[J]. 中国实验方剂学杂志, 2021, 27(18): 198-206.
[8] 曹思思, 史磊, 孙佳琳, 等. 防风的化学成分及药理作用研究进展[J]. 现代中药研究与实践, 2021, 35(1): 95-102.
[9] 韩璐, 孙甲友, 周丽, 等. 没药化学成分和药理作用研究进展[J]. 亚太传统医药, 2015, 11(3): 38-42.
[10] 李阳杰, 曹瑞梅, 毛雅君, 等. 槲皮素的结构修饰及生物活性研究进展[J]. 中草药, 2023, 54(5): 1636-1653.
[11] 李阳, 苏艳瑜, 李国豪, 等. 槲皮素通过Nrf2通路对糖尿病大鼠胰腺氧化损伤的拮抗作用机制[J]. 食品科学, 2021, 42(5): 208-214.
[12] Chen, A.Y. and Chen, Y.C. (2013) A Review of the Dietary Flavonoid, Kaempferol on Human Health and Cancer Chemoprevention. Food Chemistry, 138, 2099-2107. [Google Scholar] [CrossRef] [PubMed]
[13] 孙悦阳, 焦大志, 刘芳宇, 等. 鞣花酸通过改善线粒体功能预防糖尿病小鼠神经元凋亡[C]//中国营养学会, 中国学生营养与健康促进会. 第七届海峡两岸暨港澳营养科学大会摘要集, 2022: 37-38.
[14] 秦晓改, 卢威, 牛艳芬, 等. 黄芩苷联合罗格列酮对糖尿病小鼠周围神经病变防治研究[J]. 医学综述, 2011, 17(21): 3340-3341.
[15] Blazej, R.A.P., Knula, H., et al. (2010) Phytosterols in Physiological Con-Centrations Target Multidrug Resistant Cancer Cells. Medicine Chemistry, 6, 184-490.
[16] 曾屾, 顾志良. 鞣花酸药理作用的研究进展[J]. 常熟理工学院学报, 2023, 37(2): 72-77.
[17] 李伟, 徐伟. 黄芩苷药理作用研究进展[J]. 中西医结合研究, 2022, 14(3): 193-196.
[18] 陈玉文, 李诗琪, 黄小鹏, 等. 基于IL-6/STAT3、PI3K/Akt通路探讨汉黄芩素对LPS诱导的THP1巨噬细胞炎症模型的影响[J]. 中药材, 2022, 45(7): 1721-1725.
[19] 楼静, 崔亚娟, 刘健康, 等. 植物甾醇生理功能的线粒体调控机制[J]. 生物化学与生物物理进展, 2018, 45(12): 1240-1249.
[20] 陈宾, 牛轶雯, 谢挺, 等. 糖尿病大鼠皮肤组织糖代谢紊乱与皮肤神经病变相关性研究[J]. 中华烧伤杂志, 2011, 27(2): 139-144.
[21] 王丽, 李杰辉. AGEs-RAGE 信号通路与糖尿病难愈合创面[J]. 中国烧伤创疡杂志, 2015(6): 406-409.
[22] 袁久术, 周阳明, 王雪茹, 等. 中医药通过PI3K/Akt信号通路防治糖尿病周围神经病变的研究进展[J]. 中国实验方剂学杂志, 2023, 29(13): 1-12. [Google Scholar] [CrossRef
[23] Engelen, S.E., Robinson, A.J.B., Zurke, Y.X. and Monaco, C. (2022) Therapeutic Strategies Targeting Inflammation and Immunity in Atherosclerosis: How to Proceed? Nature Reviews Cardiology, 19, 522-542.
[24] Pandey, P. and Karupiah, G. (2022) Targeting Tumour Necrosis Factor to Ameliorate Viral Pneumonia. The FEBS Journal, 289, 883-900. [Google Scholar] [CrossRef] [PubMed]
[25] 郑超, 皮劲松, 吴艳, 等. 丝裂原活化蛋白激酶抑制剂对氧化应激鸭小肠上皮细胞屏障功能的影响[J]. 中国畜牧杂志, 2022, 58(4): 242-246.
[26] Pang, L., Lian, X., Liu, H., et al. (2020) Understanding Diabetic Neuropathy: Focus on Oxidative Stress. Oxidative Medicine and Cellular Longevity, 2020, Article ID: 9524635. [Google Scholar] [CrossRef] [PubMed]
[27] 龚思淼, 李敏, 杨彦.光生物调节治疗糖尿病周围神经病变的研究进展[J]. 医学研究生学报, 2022, 35(10): 1099-1104.